Canadian drugmaker Valeant Pharmaceuticals announced the approval of the first over-the-counter medication containing low-dose brimonidine tartrate (Lumify) for the treatment of eye redness. Source: AAO
The latest Ophthalmic Technology Assessment explores the most effective method for disinfecting reusable tonometers. Source: AAO
This Ophthalmic Technology Assessment by the Pediatric Ophthalmology/Strabismus Panel reviewed published literature regarding the efficacy of topical atropine for preventing myopic progression in children. Source: AAO
Patients with glaucoma can reliably perform self-tonometry using the portable rebound device, according to this prospective study. Source: AAO
A suite of formerly untreatable, progressively blinding retinal diseases may now be halted or even reversed, thanks to FDA approval of the gene therapy agent, Luxturna. The announcement marks the first U.S. approval of a gene therapy for an inherited disease. Source: AAO
Stealth BioTherapeutics has gained the fast-track designation for elamipretide, an eye drop aimed at improving mitochondrial function in individuals with Leber’s hereditary optic neuropathy (LHON). Source: AAO
This retrospective study evaluated outcomes of retinoblastoma treated with intravitreal melphalan as salvage for vitreous seeding. Source: AAO
Aerie Pharmaceuticals announced that the FDA has approved their once-daily glaucoma drop, Rhopressa, for lowering IOP in patients with open-angle glaucoma or ocular hypertension. Source: AAO
This week a crescent-shaped burn highlights the need for protective eyewear during solar eclipses, and fungal infections fall prey to a rose-colored eyedrop combined with green fluorescent light. Source: AAO
This is the largest study to examine long-term outcomes following allogenic ocular surface stem cell transplantation for limbal stem cell deficiency. Source: AAO
Tel: 518-580-0553
Get Directions »
Tel: 518-580-0553
Get Directions »
Tel: +1 (518) 580-0553
Get Directions »
